AJOVY is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Fremanezumab.
Product ID | 51759-202_08ae1956-25f5-4553-be30-333c558fd801 |
NDC | 51759-202 |
Product Type | Human Prescription Drug |
Proprietary Name | AJOVY |
Generic Name | Fremanezumab-vfrm |
Dosage Form | Injection |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2020-03-29 |
Marketing Category | BLA / BLA |
Application Number | BLA761089 |
Labeler Name | Teva Pharmaceuticals USA, Inc. |
Substance Name | FREMANEZUMAB |
Active Ingredient Strength | 225 mg/1.5mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2020-03-29 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA761089 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-03-29 |
Marketing Category | BLA |
Application Number | BLA761089 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2020-03-29 |
Ingredient | Strength |
---|---|
FREMANEZUMAB | 225 mg/1.5mL |
NDC | Brand Name | Generic Name |
---|---|---|
51759-202 | AJOVY | fremanezumab-vfrm |
51759-204 | AJOVY | fremanezumab-vfrm |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AJOVY 87902122 5645449 Live/Registered |
Teva Pharmaceutical Industries Limited 2018-05-01 |
AJOVY 87237174 5633449 Live/Registered |
Teva Pharmaceutical Industries Limited 2016-11-15 |